EUVIMEDEUVIMED entdecken
Crossref

Physico-Chemical Insights into the Catalytic Inhibition of Plasmodium falciparum Plasmepsin II Activity by Repurposing Fluoroquinolone Drugs

Sadaf Fatima Syed iD, Pranali Thakur, Mahendra Patil iD, Sinjan Choudhary iD

The Journal of Physical Chemistry B · 2026

DOI: 10.1021/acs.jpcb.5c05407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2026. Verfasst von Sadaf Fatima Syed und 3 weiteren Autor:innen. Beteiligte Einrichtung: UM-DAE Centre for Excellence in Basic Sciences, University of Mumbai, Vidyanagri Campus, Kalina, Mumbai 400098, India. Hauptthemen laut MEDLINE: Plasmodium falciparum, Aspartic Acid Endopeptidases, Fluoroquinolones, Antimalarials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the molecular basis of enzyme inhibition is crucial for rational drug design, particularly against parasitic targets such as Plasmodium falciparum plasmepsin II (PlmII), an aspartic protease essential for hemoglobin degradation. In this study, we repurposed fluoroquinolone drugs, namely, ofloxacin, levofloxacin, and moxifloxacin, to inhibit the catalytic activity of mature PlmII (mPlmII). Thermodynamic analyses revealed favorable enthalpic and entropic contributions that correlate with the binding strength of each drug to mPlmII. Detailed enzyme kinetics assays, combined with molecular docking studies, demonstrated that moxifloxacin, with an IC50 value of 0.15 ± 0.02 μM, exhibits the most potent inhibition, primarily through hydrogen bonding with the catalytic dyad, Asp34 and Asp214. Quantum mechanics/molecular mechanics (QM/MM) (ONIOM) calculations using B3LYP/6-31G*: UFF further corroborated this binding mode, with donor–acceptor distances ranging from 2.8 to 3.3 Å, consistent with moderate to strong hydrogen bonding. Notably, methylation of the NH group disrupts these critical interactions, altering the ligand’s positioning within the active site and resulting in weakened hydrogen bonds and reduced inhibitory efficacy. Overall, our findings reveal that precise hydrogen bonding with Asp34 and Asp214 is essential for the effective inhibition of mPlmII activity, and even minimal structural modifications, such as NH methylation, can impair active site engagement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumAspartic Acid EndopeptidasesFluoroquinolonesAntimalarialsProtozoan ProteinsMolecular Docking SimulationThermodynamicsHydrogen BondingKinetics

Substanzen

plasmepsin IIAspartic Acid EndopeptidasesFluoroquinolonesAntimalarialsProtozoan Proteins

Autor:innen und Institutionen

  • UM-DAE Centre for Excellence in Basic Sciences, University of Mumbai, Vidyanagri Campus, Kalina, Mumbai 400098, India.

ORCID-Profile: Sadaf Fatima Syed, Mahendra Patil, Sinjan Choudhary

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Syed, S. F., Thakur, P., Patil, M., & Choudhary, S. (2026). Physico-Chemical Insights into the Catalytic Inhibition of Plasmodium falciparum Plasmepsin II Activity by Repurposing Fluoroquinolone Drugs. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.5c05407

Vancouver

Syed SF, Thakur P, Patil M, Choudhary S. Physico-Chemical Insights into the Catalytic Inhibition of Plasmodium falciparum Plasmepsin II Activity by Repurposing Fluoroquinolone Drugs. The Journal of Physical Chemistry B. 2026. doi:10.1021/acs.jpcb.5c05407

BibTeX
@article{Syed2026,
  author = {Syed, Sadaf Fatima and Thakur, Pranali and Patil, Mahendra and Choudhary, Sinjan},
  title = {Physico-Chemical Insights into the Catalytic Inhibition of Plasmodium falciparum Plasmepsin II Activity by Repurposing Fluoroquinolone Drugs},
  journal = {The Journal of Physical Chemistry B},
  year = {2026},
  doi = {10.1021/acs.jpcb.5c05407}
}
Kostenlos starten →